What is NDC 10135-827?

10135-827 is the product NDC for Venlafaxine Hydrochloride, Venlafaxine hydrochloride 150 mg/1 capsule, extended release, listed with the FDA by Marlex Pharmaceuticals, Inc.. It has 4 package NDCs, shown above in 10- and 11-digit form.

Marlex Pharmaceuticals, Inc., NDC labeler code 10135. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Venlafaxine Hydrochloride?

209 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Venlafaxine Hydrochloride NDC 10135-827

NDC codes

FDA NDC Directory

Product NDC (as listed)10135-827Labeler and product segments. Claims need a package NDC.

Product NDC at billing width10135-0827Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
10135-827-10	10135082710	1000 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10135-827-10)Marketed from Aug 1, 2025
10135-827-30	10135082730	30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10135-827-30)Marketed from Aug 1, 2025
10135-827-75	10135082775	15 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10135-827-75)Marketed from Aug 1, 2025
10135-827-90	10135082790	90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (10135-827-90)Marketed from Aug 1, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Venlafaxine Hydrochloride
Generic name (nonproprietary): venlafaxine hydrochloride
Active ingredients: Venlafaxine hydrochloride — 150 mg/1
Dosage form: Capsule, Extended release
Route: Oral
Labeler: Marlex Pharmaceuticals, Inc.NDC labeler code 10135
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 201272
Marketing start: Aug 1, 2025
Listing expires: Dec 31, 2026
Other FDA classes: Norepinephrine Uptake Inhibitors (Mechanism)Serotonin Uptake Inhibitors (Mechanism)
Identifiers: Product ID 10135-827_3d59e057-318b-f098-e063-6394a90a25beSPL ID 3d59e057-318b-f098-e063-6394a90a25beSPL set ID 3c2e188f-76aa-a022-e063-6294a90abfc9RxCUI 313581, 313583, 313585UNII 7D7RX5A8MO
Pharmacologic class: Serotonin and Norepinephrine Reuptake Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N410135082710 followed by a unit qualifier and the quantity

Package 10135-0827-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 1, 2025. This label includes a boxed warning.

Indications (excerpt from the label)

Venlafaxine hydrochloride extended-release capsules are indicated in adults for the treatment of: Major Depressive Disorder (MDD) [see Clinical Studies (14.1) ] Generalized Anxiety Disorder (GAD) [see Clinical Studies (14.2) ] Social Anxiety Disorder (SAD) [see Clinical Studies (14.3) ] anic Disorder (PD) [see Clinical Studies (14.4) ] Venlafaxine hydrochloride extended-release capsules are a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of adults with: Major Depressive Disorder (MDD) ( 1 ) Generalized Anxiety Disorder (GAD) ( 1 ) Social Anxiety Disorder (SAD) ( 1 ) Panic Disorder (PD) ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 10135-827

What is NDC 10135-827?: 10135-827 is the product NDC for Venlafaxine Hydrochloride, Venlafaxine hydrochloride 150 mg/1 capsule, extended release, listed with the FDA by Marlex Pharmaceuticals, Inc.. It has 4 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Venlafaxine Hydrochloride.
What is the active ingredient?: Venlafaxine hydrochloride.
Who is the labeler?: Marlex Pharmaceuticals, Inc., NDC labeler code 10135. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Venlafaxine Hydrochloride?: 209 other product NDCs are listed under this name. See all Venlafaxine Hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Venlafaxine Hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Venlafaxine Hydrochloride	Venlafaxine hydrochloride 37.5 mg/1	Capsule, Extended releaseOral	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	24658-125	24658-0125-1024658-0125-3024658-0125-90
Venlafaxine Hydrochloride	Venlafaxine hydrochloride 75 mg/1	Capsule, Extended releaseOral	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	24658-126	24658-0126-1024658-0126-3024658-0126-90
Venlafaxine Hydrochloride	Venlafaxine hydrochloride 150 mg/1	Capsule, Extended releaseOral	PURACAP LABORATORIES LLC DBA BLU PHARMACEUTICALS	24658-127	24658-0127-0524658-0127-3024658-0127-90
Venlafaxine Hydrochloride	Venlafaxine hydrochloride 75 mg/1	Capsule, Extended releaseOral	Coupler LLC	67046-0390	67046-0390-03
Venlafaxine Hydrochloride	Venlafaxine hydrochloride 37.5 mg/1	Capsule, Extended releaseOral	Coupler LLC	67046-0527	67046-0527-03
Venlafaxine Hydrochloride	Venlafaxine hydrochloride 37.5 mg/1	Capsule, Extended releaseOral	NorthStar RxLLC	72603-747	72603-0747-01
Venlafaxine Hydrochloride	Venlafaxine hydrochloride 75 mg/1	Capsule, Extended releaseOral	NorthStar RxLLC	72603-748	72603-0748-01
Venlafaxine Hydrochloride	Venlafaxine hydrochloride 150 mg/1	Capsule, Extended releaseOral	NorthStar RxLLC	72603-749	72603-0749-01
Venlafaxine Hydrochloride	Venlafaxine hydrochloride 75 mg/1	Capsule, Extended releaseOral	REMEDYREPACK INC.	70518-4632	70518-4632-00
Venlafaxine Hydrochloride	Venlafaxine hydrochloride 37.5 mg/1	Capsule, Extended releaseOral	Advanced Rx of Tennessee, LLC	80425-0581	80425-0581-0180425-0581-0280425-0581-03

All 210 Venlafaxine Hydrochloride NDCs

Other NDCs under ANDA 201272

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 201272
Product	Strength	Form · route	Labeler	Product NDC
Venlafaxine Hydrochloride	Venlafaxine hydrochloride 37.5 mg/1	Capsule, Extended releaseOral	Marlex Pharmaceuticals, Inc.	10135-825
Venlafaxine Hydrochloride	Venlafaxine hydrochloride 75 mg/1	Capsule, Extended releaseOral	Marlex Pharmaceuticals, Inc.	10135-826